EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $406,000 | -21.2% | 8,196 | -19.0% | 0.01% | -17.6% |
| Q4 2021 | $515,000 | -14.3% | 10,118 | -6.1% | 0.02% | -15.0% |
| Q3 2021 | $601,000 | +44.8% | 10,771 | +11.1% | 0.02% | +42.9% |
| Q2 2021 | $415,000 | +1.7% | 9,692 | -0.8% | 0.01% | 0.0% |
| Q1 2021 | $408,000 | -57.7% | 9,775 | -39.2% | 0.01% | -60.0% |
| Q4 2019 | $965,000 | -19.4% | 16,065 | -24.1% | 0.04% | -18.6% |
| Q3 2019 | $1,197,000 | -14.4% | 21,163 | -15.8% | 0.04% | 0.0% |
| Q2 2019 | $1,399,000 | -12.3% | 25,130 | -20.4% | 0.04% | -8.5% |
| Q1 2019 | $1,595,000 | – | 31,582 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |